CASI Pharmaceuticals
CASI
#9771
Rank
S$39.38 M
Marketcap
$2.54
Share price
0.46%
Change (1 day)
-16.56%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -S$51.06 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$28.53 Million. a decrease over its 2023 earnings that were of -S$34.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 -S$49.92 Million44.35%
2023 -S$34.59 Million-29.55%
2022 -S$49.09 Million4.43%
2021 -S$47 Million-24.56%
2020 -S$62.31 Million4.74%
2019 -S$59.49 Million65.13%
2018 -S$36.03 Million155.07%
2017 -S$14.13 Million13.93%
2016 -S$12.4 Million31.18%
2015 -S$9.45 Million-72.5%
2014 -S$34.36 Million356.62%
2013 -S$7.53 Million-60.55%
2012 -S$19.08 Million218.41%
2011 -S$5.99 Million0.74%
2010 -S$5.95 Million-32.54%
2009 -S$8.82 Million-66.98%
2008 -S$26.7 Million-14.22%
2007 -S$31.12 Million7.04%
2006 -S$29.08 Million27.95%
2005 -S$22.73 Million4.51%
2004 -S$21.75 Million-15.84%
2003 -S$25.84 Million-55.29%
2002 -S$57.79 Million-34.05%
2001 -S$87.62 Million31.73%
2000 -S$66.51 Million31.56%
1999 -S$50.56 Million145.56%
1998 -S$20.59 Million76.4%
1997 -S$11.68 Million36.92%
1996 -S$8.53 Million